Chronic Kidney Disease Trial, Recruiting NCT07107919 Sponsor: The Affiliated Hospital of Qingdao University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07107919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old (any sex)
  • You have been diagnosed with chronic kidney disease (CKD) based on recognised medical guidelines
  • Your medical records and health information are complete and available
  • You are willing and able to give written permission to take part in the study and to have a special type of body scan called a PET/MR scan
  • If you are female, you agree to use reliable birth control during the study and for at least 6 months after it ends (for example, contraceptive pills, an IUD, condoms, sterilisation, abstinence, or a vasectomised partner); if you are male, you also agree to use contraception during the study and for 6 months after it ends

Who may not be able to join:

  • You are pregnant, planning to become pregnant, or currently breastfeeding
  • You have a reason you cannot have a PET/MR scan, such as certain metal implants in your body, severe claustrophobia (fear of enclosed spaces), or breathing difficulties that make lying still in the scanner very difficult
  • You have had a previous allergic reaction to a type of dye called a gadolinium-based contrast agent, which is sometimes used in scans
  • You have been diagnosed with cancer or another serious illness that is actively getting worse
  • You have a serious heart condition, such as advanced heart failure, severe problems with your heart valves, or a disease affecting the heart muscle
  • Your blood pressure or circulation is currently unstable (confirm with trial site)
  • You have a severe infection or another serious health condition alongside your kidney disease
  • Your medical records are incomplete or missing important information
  • The study team has any other concerns about whether it is safe or appropriate for you to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Affiliated Hospital of Qingdao University
Registry
ClinicalTrials.gov
Start date
30 July 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Myocardial fibrosis burden measured by 18F-FAPI PET/MR; Myocardial fibrosis burden measured by 18F-FAPI PET/MR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov